Data Storage on DNA Can Keep It Safe for Centuries
By John Markoff,
The New York Times
| 12. 03. 2015
Untitled Document
SEATTLE — Computer data has been depicted as microscopic magnetic smudges, electric charges and even Lilliputian patterns of dots that reflect laser beams. It may ultimately move into the fabric of life itself — encoded in the organic molecules that are strung together like pearls to form strands of DNA.
In two recent experiments, a team of computer scientists at the University of Washington and Microsoft, and a separate group at the University of Illinois, have shown that DNA molecules can be the basis for an archival storage system potentially capable of storing all of the world’s digital information in roughly nine liters of solution, about the amount of liquid in a case of wine.
The new research demonstrates that specific digital files can be retrieved from a potentially vast pool of data. The new storage technology would also be capable of keeping immense amounts of information safely for a millennium or longer, researchers said.
It would also address a glaring Achilles’ heel at the heart of microelectronic data storage systems: Magnetic disks, tape and even...
Related Articles
By Sarah Zhang, The Atlantic | 03.18.2024
People are discovering the truth about their biological parents with DNA—and learning that incest is far more common than many think.
When Steve Edsel was a boy, his adoptive parents kept a scrapbook of newspaper clippings in their bedroom closet...
By Antonio Regalado, MIT Technology Review | 03.20.2024
There is a new most expensive drug ever—a gene therapy that costs as much as a Brooklyn brownstone or a Miami mansion, and more than the average person will earn in a lifetime.
Lenmeldy is a gene treatment for metachromatic...
By Carl Zimmer, The New York Times | 03.10.2024
In 1889, a French doctor named Francois-Gilbert Viault climbed down from a mountain in the Andes, drew blood from his arm and inspected it under a microscope. Dr. Viault’s red blood cells, which ferry oxygen, had surged 42 percent. He...
By Nick Paul Taylor, BioSpace | 03.14.2024
A U.K. watchdog balked at the cost-effectiveness of Vertex Pharmaceuticals’ CRISPR-based sickle cell disease therapy Thursday, recommending against funding the treatment unless uncertainties can be cleared up satisfactorily.
The U.K. became the first country to authorize Vertex’s Casgevy (exagamglogene...